Welcome, Guest. Please login or register.
April 24, 2024, 06:40:16 pm

Login with username, password and session length


Members
  • Total Members: 37651
  • Latest: Toropi_
Stats
  • Total Posts: 773288
  • Total Topics: 66348
  • Online Today: 567
  • Online Ever: 5484
  • (June 18, 2021, 11:15:29 pm)
Users Online
Users: 0
Guests: 556
Total: 556

Welcome


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Do I Have HIV?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: DoxyPEP  (Read 6168 times)

0 Members and 2 Guests are viewing this topic.

Offline Jim Allen

  • Administrator
  • Member
  • Posts: 22,388
  • Threads: @jim16309
    • Social Media: Threads
DoxyPEP
« on: October 05, 2023, 11:11:57 am »
POZ.com article in full: https://www.poz.com/article/cdc-issues-first-doxypep-guidelines

In Brief:
Quote
The Centers for Disease Control and Prevention (CDC) has issued its first proposed guidelines for using the antibiotic doxycycline as post-exposure prophylaxis to prevent bacterial sexually transmitted infections (STIs), an approach known as doxyPEP. The guidelines, published in the Federal Register on October 2, will be open for public comment for 45 days. https://www.federalregister.gov/documents/2023/10/02/2023-21725/guidelines-for-the-use-of-doxycycline-post-exposure-prophylaxis-for-bacterial-sexually-transmitted

The proposed guidelines state that a single 200 milligram dose of oral doxycycline taken within 72 hours after oral, vaginal or anal sex should be considered for gay, bisexual and other men who have sex with men and for transgender women who have had gonorrhea, chlamydia or syphilis at least once during the past year. This is a strong recommendation supported by data from clinical trials.

The draft also says that doxyPEP “could be considered” for men who have sex with men and transgender women who have not been diagnosed with an STI if they “will be participating in sexual activities that are known to increase likelihood of exposure to STIs, e.g., during weekend events, cruises and festivals,” although this has not been directly assessed in trials.

Due to a lack of supporting evidence, however, the guidelines state that “no recommendation can be given at this time” on the use of doxyPEP for cisgender women, cisgender heterosexual men, transgender men or other queer or non-binary people.

According to the guidelines, doxyPEP “should be implemented in the context of a comprehensive sexual health approach including risk reduction counseling, STI screening and treatment, recommended vaccination and linkage to HIV pre-exposure prophylaxis (PrEP), HIV care or other services, as appropriate.”

HIV 101 - Everything you need to know
HIV 101
Read more about Testing here:
HIV Testing
Read about Treatment-as-Prevention (TasP) here:
HIV TasP
You can read about HIV prevention here:
HIV prevention
Read about PEP and PrEP here
PEP and PrEP

My Instagram
Threads

Offline numbersguy82

  • Member
  • Posts: 566
  • Adrian Alan
    • Instagram
Re: DoxyPEP
« Reply #1 on: October 06, 2023, 04:45:35 am »
Interesting, but this kind of contradicts the whole “widespread use of antibiotics unnecessarily will create resistance” argument. I used to have a roomie that would take a trip to NyC every year. He’d make an appt before he even left, to visit the clinic, so upon his return he could get treated for the various STIs he’d collect while there.

Also the main argument against prep, that I’ve heard, has been that HIV isn’t the only thing you can get while engaging in unprotected sex. So maybe this will actually increase HIV prep usage.
JOIN US FOR PEER-ish SUPPORT Every other Friday @ 7pm EST, PM me your email address for meeting link/information

Strive for “One Day When” by collecting “One Day Wins”

Offline Jim Allen

  • Administrator
  • Member
  • Posts: 22,388
  • Threads: @jim16309
    • Social Media: Threads
Re: DoxyPEP
« Reply #2 on: January 25, 2024, 05:15:51 am »

DoxyPEP 101
https://www.poz.com/article/doxy-pep-101

Quote
Here’s how doxyPEP works: A single 200 milligram dose of doxycycline is taken ideally within 24 hours—but no later than 72 hours—after anal, vaginal or oral sex. Doxycycline can be taken on consecutive days if sex is repeated, but no more than one dose in a 24-hour period. It is safe to take doxycycline with PrEP.

Quote
As part of the IPERGAY trial, a French PrEP study, a subgroup of 232 men who have sex with men were randomized to receive a single dose of doxycycline within 24 hours after sex or no STI prophylaxis. In 2017, Jean-Michel Molina, MD, of the University of Paris Cité, and colleagues reported that doxyPEP lowered the risk of chlamydia by 70% and syphilis by 73%, but it did not significantly reduce gonorrhea risk.

Quote
At the 2022 International AIDS Conference in Montreal, Annie Luetkemeyer, MD, of the University of California San Francisco, reported that doxycycline reduced STI diagnoses by 62% per quarter for HIV-positive participants and by 66% for people on PrEP. STIs were diagnosed at 11% to 12% of quarterly visits in the doxycycline group versus 31% to 32% in the standard care group. But here, too, the risk reduction was greater for chlamydia (74% in the HIV-positive group and 88% in the PrEP group) and syphilis (77% and 87%, respectively) than for gonorrhea (57% and 55%, respectively).
HIV 101 - Everything you need to know
HIV 101
Read more about Testing here:
HIV Testing
Read about Treatment-as-Prevention (TasP) here:
HIV TasP
You can read about HIV prevention here:
HIV prevention
Read about PEP and PrEP here
PEP and PrEP

My Instagram
Threads

Offline Jim Allen

  • Administrator
  • Member
  • Posts: 22,388
  • Threads: @jim16309
    • Social Media: Threads
Re: DoxyPEP
« Reply #3 on: March 05, 2024, 04:59:25 pm »

By Liz Highleyman, POZ.com Article in full: https://www.poz.com/article/doxypep-rollout-leads-drop-stis-san-francisco

In Brief:

Quote
In October 2022, San Francisco was the first city to recommend doxyPEP for gay and bisexual men and transgender people. Over the next year, chlamydia cases dropped steeply and syphilis also fell, but the decline in gonorrhea was minimal. The new results from clinical practice and population-level analyses are consistent with findings from recent clinical trials.
HIV 101 - Everything you need to know
HIV 101
Read more about Testing here:
HIV Testing
Read about Treatment-as-Prevention (TasP) here:
HIV TasP
You can read about HIV prevention here:
HIV prevention
Read about PEP and PrEP here
PEP and PrEP

My Instagram
Threads

 


Terms of Membership for these forums
 

© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.